Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 102

    1.

    Attributable cost of methicillin resistance: an issue that is difficult to evaluate.

    Timsit JF.

    Crit Care. 2006;10(4):157. Review.PMID: 16934109 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia.

    Shorr AF, Tabak YP, Gupta V, Johannes RS, Liu LZ, Kollef MH.

    Crit Care. 2006;10(3):R97. Epub 2006 Jun 29.PMID: 16808853 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Impact of methicillin resistance on mortality in Staphylococcus aureus VAP: a systematic review.

    Athanassa Z, Siempos II, Falagas ME.

    Eur Respir J. 2008 Mar;31(3):625-32. Review.PMID: 18310398 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Methicillin resistance and its relation to prognosis in patients with ventilator-associated pneumonia: still an unsolved issue.

    Santos RP, Wolff FH, Fuchs FD.

    Clin Infect Dis. 2006 May 1;42(9):1343. No abstract available. PMID: 16586396 [PubMed - indexed for MEDLINE]Related articles

    5.

    Bacteremia in patients with ventilator-associated pneumonia is associated with increased mortality: A study comparing bacteremic vs. nonbacteremic ventilator-associated pneumonia.

    Agbaht K, Diaz E, Muñoz E, Lisboa T, Gomez F, Depuydt PO, Blot SI, Rello J.

    Crit Care Med. 2007 Sep;35(9):2064-70.PMID: 17581489 [PubMed - indexed for MEDLINE]Related articles

    6.

    Is the end-game penetration (of the airway)?

    Lipman J.

    Crit Care Med. 2005 Jul;33(7):1654-5. No abstract available. PMID: 16003083 [PubMed - indexed for MEDLINE]Related articles

    7.

    Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.

    Estes L, Orenstein R.

    Clin Ther. 2007 Feb;29(2):381-3; author reply 383-4. No abstract available. PMID: 17472831 [PubMed - indexed for MEDLINE]Related articles

    9.

    Ventilator-associated pneumonia: impact of organisms on clinical resolution and medical resources utilization.

    Vidaur L, Planas K, Sierra R, Dimopoulos G, Ramirez A, Lisboa T, Rello J.

    Chest. 2008 Mar;133(3):625-32. Epub 2008 Jan 15.PMID: 18198250 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Inadequate treatment of ventilator-associated pneumonia: risk factors and impact on outcomes.

    Teixeira PJ, Seligman R, Hertz FT, Cruz DB, Fachel JM.

    J Hosp Infect. 2007 Apr;65(4):361-7. Epub 2007 Mar 12.PMID: 17350721 [PubMed - indexed for MEDLINE]Related articles

    12.

    Ventilator-associated pneumonia due to colistin susceptible-only microorganisms.

    Rios FG, Luna CM, Maskin B, Saenz Valiente A, Lloria M, Gando S, Sosa C, Baquero S, Llerena C, Petrati C, Apezteguia C.

    Eur Respir J. 2007 Aug;30(2):307-13. Epub 2007 May 15.PMID: 17504791 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Fatal bacteraemic pneumonia due to community-acquired methicillin-resistant Staphylococcus aureus.

    Hsu LY, Tambyah PA.

    Singapore Med J. 2006 Nov;47(11):1010-1; author reply 1011. No abstract available. PMID: 17075677 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Emergence of staphylococcal cassette chromosome mec type IV methicillin-resistant Staphylococcus aureus as a cause of ventilator-associated pneumonia.

    Neofytos D, Kuhn B, Shen S, Hua Zhu X, Jungkind D, Flomenberg P.

    Infect Control Hosp Epidemiol. 2007 Oct;28(10):1206-9. Epub 2007 Aug 29.PMID: 17828701 [PubMed - indexed for MEDLINE]Related articles

    15.

    Ventilator-associated pneumonia in neonatal and pediatric intensive care unit patients.

    Foglia E, Meier MD, Elward A.

    Clin Microbiol Rev. 2007 Jul;20(3):409-25, table of contents. Review.PMID: 17630332 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    [Ventilator-associated pneumonia and chronic obstructive pulmonary disease]

    Rammaert B, Ader F, Nseir S.

    Rev Mal Respir. 2007 Dec;24(10):1285-98. Review. French. PMID: 18216749 [PubMed - indexed for MEDLINE]Related articles

    17.

    Methicillin-resistant Staphylococcus aureus pneumonia after thoracic surgery: successful treatment with linezolid after failed vancomycin therapy.

    Salerno D, Vahid B, Marik PE.

    Ann Thorac Surg. 2007 May;83(5):1888-91.PMID: 17462428 [PubMed - indexed for MEDLINE]Related articles

    18.

    Early predictors for infection recurrence and death in patients with ventilator-associated pneumonia.

    Combes A, Luyt CE, Fagon JY, Wolff M, Trouillet JL, Chastre J.

    Crit Care Med. 2007 Jan;35(1):146-54.PMID: 17080004 [PubMed - indexed for MEDLINE]Related articles

    19.

    Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.

    Mullins CD, Kuznik A, Shaya FT, Obeidat NA, Levine AR, Liu LZ, Wong W.

    Clin Ther. 2006 Aug;28(8):1184-98.PMID: 16982296 [PubMed - indexed for MEDLINE]Related articles

    20.

    Comparative cost of selective screening to prevent transmission of methicillin-resistant Staphylococcus aureus (MRSA), compared with the attributable costs of MRSA infection.

    Gavaldà L, Masuet C, Beltran J, Garcia M, Garcia D, Sirvent JM, Ramon JM.

    Infect Control Hosp Epidemiol. 2006 Nov;27(11):1264-6. Epub 2006 Sep 28.PMID: 17080390 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data